SPC-15

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameSPC-15
Drug Alias NameSPC-15
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesSilo Pharma Inc
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-TraumaticAnxiety Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A